Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Mu

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Nature Communications|March 26, 2026
A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADARYang Yi, Yanqiang Li, Rui Wang, et al.
Science (New York, N.Y.)|January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancerPing Mu, Zeda Zhang, Matteo Benelli, et al.
Nature Cancer|September 6, 2022
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.
Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.
Cancer Cell|July 18, 2020
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate CancerZeda Zhang, Wouter R Karthaus, Young Sun Lee, et al.
Cancer Cell|March 30, 2020
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin DysregulationZeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
Journal of Cancer|April 25, 2020
Can Combined Screening of Ultrasound and Elastography Improve Breast Cancer Identification Compared with MRI in Women with Dense Breasts-a Multicenter Prospective StudyLu-Ying Gao, Yang Gu, Wen Xu, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Nature Communications|March 26, 2026
A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADARYang Yi, Yanqiang Li, Rui Wang, et al.
Science (New York, N.Y.)|January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancerPing Mu, Zeda Zhang, Matteo Benelli, et al.
Nature Cancer|September 6, 2022
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.
Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.
Cancer Cell|July 18, 2020
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate CancerZeda Zhang, Wouter R Karthaus, Young Sun Lee, et al.
Cancer Cell|March 30, 2020
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin DysregulationZeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
Journal of Cancer|April 25, 2020
Can Combined Screening of Ultrasound and Elastography Improve Breast Cancer Identification Compared with MRI in Women with Dense Breasts-a Multicenter Prospective StudyLu-Ying Gao, Yang Gu, Wen Xu, et al.
Pageof 19